IRE favicon


Resource ID: #21567
Subject: Medical Reporting
Source: Los Angeles Times
Date: Dec. 22



This series examines how payments from drug companies to scientists at the National Institutes of Health cause a conflict of interest that affects health care and policy recommendations. Even under the partial reforms announced by the presidentially appointed NIH director in 2004, some NIH scientists would still be able to take compensation such as stock options and consulting fees.

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram